跳至主要内容
RestrictedBinding ruleKRNo English translation已检查官方来源导入

살리실릭애씨드 및그 염류

Listed by the Korean MFDS as a cosmetic ingredient requiring conditions of use.

监管决定及完整条件

状态
Restricted
法律地位
Binding rule
监管摘要
Listed by the Korean MFDS as a cosmetic ingredient requiring conditions of use.
条件与限制

살리실릭애씨드 로서 0.5% · 영유아용 제품류 또는 만 13세 이하 어린이가 사용할 수 있음을 특정하여 표시하는 제품에는 사용금지(다만, 샴푸는 제외) · 살리실릭애씨드칼슘살리실레이트마그네슘살리실레이트

物质身份

官方来源名称
살리실릭애씨드 및그 염류
CAS
69-72-7; 824-35-1; 18917-89-0
EC
200-712-3
身份映射
cas_number
关联成分
SALICYLIC ACID

关联的 CosIng 身份数据

名称和别名

SALICYLIC ACIDsalicylic acidacidum salicylicum

CosIng 描述: Salicylic acid

欧盟清单限制备注: III/98 V/3

已记录的化妆品功能: ANTI-SEBORRHEIC, FRAGRANCE, HAIR CONDITIONING, KERATOLYTIC, PRESERVATIVE, SKIN CONDITIONING

功能页面:ANTI-SEBORRHEIC, FRAGRANCE, HAIR CONDITIONING, KERATOLYTIC, PRESERVATIVE, SKIN CONDITIONING

查看完整的成分档案

该身份的跨市场概览

本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。

9 个市场数据集

European Union

Restricted entry found

2 条关联记录 · 2 条含特定条件

打开支持记录

Great Britain

Permitted list with conditionsRestricted

2 条关联记录 · 2 条含特定条件

打开支持记录

New Zealand

Permitted list with conditionsRestricted

4 条关联记录 · 4 条含特定条件

打开支持记录

ASEAN

Permitted list with conditionsRestricted

2 条关联记录 · 2 条含特定条件

打开支持记录

South Korea

当前记录
Restricted

2 条关联记录 · 2 条含特定条件

打开支持记录
CAS 18917-89-0 的 PubChem 二维化学结构
CAS 18917-89-0PubChem CID 54684589

CAS 18917-89-0 的已核实化学信息

(T-4)-Bis(2-(hydroxy-kappaO)benzoato-kappaO)magnesium

Magnesium salicylate is a non-steroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain. It is available in several over-the-counter (OTC) formulations. Though the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate), effective pain relief is often found with a half dosage, with reduced anti-inflammatory results. — DrugBank

IUPAC 名称
magnesium bis(2-carboxyphenolate)
分子式
C14H10MgO6
分子量
298.53 g/mol
精确质量
298.0327797 Da
单同位素质量
298.0327797 Da
拓扑极性表面积
121.0 Ų
分子复杂度
133.0
形式电荷
0
氢键供体
2
氢键受体
6
可旋转键
2
重原子
21
共价单元
3

向 PubChem 报告的名称和同义词

Magnesium salicylateMagnesium salicylate anhydrousMagnesium disalicylateBackache reliefJQ69D454N1Backache CapletsBayer Select BackacheBackprin
另有 16 个已报告名称
DoansBack Pain ReliefDoans Extra StrengthDoans Maximum StrengthMedique Back Pain ReliefRefChem:408391Unishield Back Pain ReliefMaximum Strength Backache ReliefMedique at Home Back Pain ReliefBack Pain Relief Extra Strength Doans242-669-3Magnesium Salicylate TetrahydrateMaganmagnesiumsalicylateMobidinmagnesium;2-carboxyphenolate
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Mg+2]
InChI
InChI=1S/2C7H6O3.Mg/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2
InChIKey
MQHWFIOJQSCFNM-UHFFFAOYSA-L

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 69-72-7 的 PubChem 二维化学结构
CAS 69-72-7PubChem CID 338

CAS 69-72-7 的已核实化学信息

Salicylic Acid

Salicylic acid is a monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves. It has a role as an antiinfective agent, an antifungal agent, a plant hormone, a keratolytic drug, an EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor, a plant metabolite and an algal metabolite. It is a conjugate acid of a salicylate. — ChEBI

IUPAC 名称
2-hydroxybenzoic acid
分子式
C7H6O3
分子量
138.12 g/mol
精确质量
138.031694049 Da
单同位素质量
138.031694049 Da
XLogP3
2.3
拓扑极性表面积
57.5 Ų
分子复杂度
133.0
形式电荷
0
氢键供体
2
氢键受体
3
可旋转键
1
重原子
10
共价单元
1

向 PubChem 报告的名称和同义词

o-hydroxybenzoic acid2-Carboxyphenolo-CarboxyphenolRetarder WRutranexSalonilKeralytDuoplant
另有 16 个已报告名称
FreezoneSaligelIonilPsoriacid-S-stiftBenzoic acid, 2-hydroxy-Stri-DexSalicylic acid soapVerrugonSalicylic acid collodionPhenol-2-carboxylic acid2-Hydroxybenzenecarboxylic acidTrans-Ver-SalOrthohydroxybenzoic acidAcidum salicylicumAcido salicilicoIonil-Plus
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
5
三维环
1
三维疏水基团
0
三维受体特征
2
三维供体特征
1
三维阴离子中心
1
三维阳离子中心
0
三维构象异构体
3
有效三维可旋转键
1.0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)O
InChI
InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)
InChIKey
YGSDEFSMJLZEOE-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 824-35-1 的 PubChem 二维化学结构
CAS 824-35-1PubChem CID 54684600

CAS 824-35-1 的已核实化学信息

Calcium Salicylate

The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Calcium Salicylate... — Cosmetic Ingredient Review (CIR)

IUPAC 名称
calcium bis(2-carboxyphenolate)
分子式
C14H10CaO6
分子量
314.30 g/mol
精确质量
314.0103289 Da
单同位素质量
314.0103289 Da
拓扑极性表面积
121.0 Ų
分子复杂度
133.0
形式电荷
0
氢键供体
2
氢键受体
6
可旋转键
2
重原子
21
共价单元
3

向 PubChem 报告的名称和同义词

Calcium disalicylateBenzoic acid, 2-hydroxy-, calcium salt (2:1)0841QCS0DKRefChem:573557212-525-4Calcium 2-hydroxybenzoateUNII-0841QCS0DKEINECS 212-525-4
另有 5 个已报告名称
CALCIUMSALICYLATEcalcium bis(2-hydroxybenzoate)CALCIUM SALICYLATE [II]CALCIUM SALICYLATE [WHO-DD]DB-056609
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Ca+2]
InChI
InChI=1S/2C7H6O3.Ca/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2
InChIKey
VBIGULIJWJPALH-UHFFFAOYSA-L

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

官方来源与出处

已登记来源
South Korea MFDS cosmetic ingredient data
来源参考
화장품 안전기준 등에 관한 규정, 별표 2, record 2-50
来源记录 ID
2-50
来源版本
2026-19
来源语言
Korean
翻译状态
No English translation
生效日期
2026-03-18
来源更新
2026-03-18
快照检查时间
2026-08-30 04:33 UTC
验证方法
MFDS JSON appendices 1–2 parse; 1077 prohibited, 243 restricted
SHA-256
056de35b843a5e31f709073f9e79d5e6e18f7c9164eb537bb099b185a37ef7d8

已登记的数据集备注

数据集覆盖范围
Ingredient identity and separate restriction/regulation data endpoints
权威性说明
Korean source is canonical; English materials alone are not complete enough for certification

本记录在市场数据集中的位置

1320
条当前 South Korea 记录
243
条标记为 Restricted 的记录
1320
条来自此来源版本的记录
1252
条带有 CAS 身份的市场记录

状态分布

在 1320 条当前记录中,有 638 条带有条件文本。条件字段为空时,按上述记录类型解释;绝不会被转换为可无限制使用的声明。

South Korea 市场背景

Complete current appendix dataset

覆盖版本: MFDS Notice 2026-19, effective 18 March 2026

All rows in official Appendix 1 (prohibited) and Appendix 2 (restricted) of the Safety Standards for Cosmetics.

核实清单

  1. Match the Korean canonical substance name and identifiers.
  2. Review all Appendix 1 and 2 matches and conditions.
  3. Check functional-cosmetic and positive-list requirements where applicable.
  4. Confirm current MFDS notice, responsible seller and label obligations.

官方市场来源

核实工作流程与记录完整性

在将此结果用于合规决定之前

  1. 确认“살리실릭애씨드 및그 염류”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
  2. Match the Korean canonical substance name and identifiers.
  3. Review all Appendix 1 and 2 matches and conditions.
  4. Check functional-cosmetic and positive-list requirements where applicable.
  5. Confirm current MFDS notice, responsible seller and label obligations.
  6. 记录来源版本,并在生产、备案或上市之前重新核查监管机构。

本记录中的可用字段

  • 官方物质名称可用
  • CAS可用
  • EC可用
  • 单独的条件文本可用
  • 生效日期可用
  • 快照哈希与方法可用

本页回答的问题

This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record. Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.

If this row does not reproduce conditions, open the cited official detail because omission does not mean unrestricted use. Korean source wording is canonical and other positive lists/notices may still apply to the formulation.

该记录引用 화장품 안전기준 등에 관한 규정, 별표 2, record 2-50,来源版本 2026-19。 打开官方来源。

不保证。CAS 有助于确定身份,但各辖区可能对同一物质作出不同分类,并可能适用不同的产品范围、限值、警示语和过渡日期。

稳定引用

살리실릭애씨드 및그 염류. 화장품 안전기준 등에 관한 규정, 별표 2, record 2-50. South Korea. Source version 2026-19. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/kr/records/1913/

请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。

South Korea 的解读与局限

This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.

Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.

如何解读法律地位

The cited row forms part of a binding rule or legally incorporated list for this market.

本页证据

  • 记录结果:Restricted
  • 法律地位:Binding rule
  • 来源版本:2026-19
  • 生效日期:2026-03-18

它不能证明什么

Korean source wording is canonical and other positive lists/notices may still apply to the formulation.

进一步的权威物质研究

这些来源均不能推翻上述市场决定。

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

在来源处研究此身份

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

在来源处研究此身份

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

在来源处研究此身份

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

在来源处研究此身份

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

在来源处研究此身份

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

在来源处研究此身份

US EPA CompTox CTX APIs

导入需要 API 密钥

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

在来源处研究此身份